Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Analysis and Prediction of the COVID-19 outbreak in Pakistan

View ORCID ProfileMohsin Ali, View ORCID ProfileMudassar Imran, View ORCID ProfileAdnan Khan
doi: https://doi.org/10.1101/2020.06.21.20136341
Mohsin Ali
1Department of Mathematics, Lahore University of Management Sciences, Opposite Sector ‘U’, DHA Lahore 54792, Pakistan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mohsin Ali
Mudassar Imran
2Department of Mathematics and Natural Sciences, Gulf University for Science & Technology, Mishref, Kuwait
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mudassar Imran
Adnan Khan
1Department of Mathematics, Lahore University of Management Sciences, Opposite Sector ‘U’, DHA Lahore 54792, Pakistan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adnan Khan
  • For correspondence: adnan.khan@lums.edu.pk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

In this study we estimate the severity of the COVID-19 outbreak in Pakistan prior to and after lock down restrictions were eased. We also project the epidemic curve considering realistic quarantine, social distancing and possible medication scenarios. We use a deterministic epidemic model that includes asymptomatic, quarantined, isolated and medicated population compartments for our analysis. We calculate the basic reproduction number ℛ0 for the pre and post lock down periods, noting that during this time no medication was available.1 The pre-lock down value of ℛ0 is estimated to be 1.07 and the post lock down value is estimated to be 1.86. We use this analysis to project the epidemic curve for a variety of lock down, social distancing and medication scenarios. We note that if no substantial efforts are made to contain the epidemic, it will peak in mid of September, with the maximum projected active cases being close to 700,000. In a realistic, best case scenario, we project that the epidemic peaks in early to mid July with the maximum active cases being around 120000.We note that social distancing measures and medication if available will help flatten the curve, however without the reintroduction of further lock down it would be very difficult to bring ℛ0 below 1. Our study strongly supports the recent WHO recommendation of reintroducing lock downs to control the epidemic.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

no funds were available during this project

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* Author email: mohsin_ali{at}lums.edu.pk

  • ↵† Author email: mimran{at}asu.edu

  • 1 Data data availability statement : The data that support the findings of this study are openly available in at COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University [https://github.com/CSSEGISandData/COVID-19], reference number [32].

Data Availability

https://github.com/CSSEGISandData/COVID-19

https://github.com/CSSEGISandData/COVID-19

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted June 23, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Analysis and Prediction of the COVID-19 outbreak in Pakistan
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Analysis and Prediction of the COVID-19 outbreak in Pakistan
Mohsin Ali, Mudassar Imran, Adnan Khan
medRxiv 2020.06.21.20136341; doi: https://doi.org/10.1101/2020.06.21.20136341
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Analysis and Prediction of the COVID-19 outbreak in Pakistan
Mohsin Ali, Mudassar Imran, Adnan Khan
medRxiv 2020.06.21.20136341; doi: https://doi.org/10.1101/2020.06.21.20136341

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (214)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1091)
  • Dentistry and Oral Medicine (194)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (497)
  • Epidemiology (9747)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2298)
  • Geriatric Medicine (221)
  • Health Economics (461)
  • Health Informatics (1548)
  • Health Policy (729)
  • Health Systems and Quality Improvement (600)
  • Hematology (236)
  • HIV/AIDS (500)
  • Infectious Diseases (except HIV/AIDS) (11619)
  • Intensive Care and Critical Care Medicine (615)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2136)
  • Nursing (133)
  • Nutrition (332)
  • Obstetrics and Gynecology (424)
  • Occupational and Environmental Health (516)
  • Oncology (1171)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (308)
  • Pediatrics (692)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2168)
  • Public and Global Health (4640)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (450)
  • Respiratory Medicine (622)
  • Rheumatology (273)
  • Sexual and Reproductive Health (224)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (42)
  • Transplantation (120)
  • Urology (94)